Atossa Genetics (ATOS) Misses Q2 EPS by 1c

Atossa Genetics (NASDAQ: ATOS) reported Q2 EPS of ($0.07), $0.01 worse than the analyst estimate of ($0.06).

For earnings history and earnings-related data on Atossa Genetics (ATOS) click here.

You May Also Be Interested In

• Zhipu AI prices HK offering at HK$1,588/share - Reuters
• Goldman Sachs Upgrades Glencore Plc (GLEN:LN) to Buy
• Voya Financial estimates Q2 alternative investment pre-tax loss of $9M-$19M